Power Integrations SEC filings document a Delaware semiconductor company focused on high-voltage power conversion. Its Form 8-K reports include quarterly results releases, executive appointments, compensatory arrangements, revisions to indemnification agreements, amendments to bylaws and changes to equity award plans, including the Amended and Restated 2025 Inducement Award Plan used for restricted stock units, performance stock units and related inducement awards.
The company’s proxy materials cover board elections, executive compensation, pay-versus-performance disclosures, shareholder voting matters and governance practices. These filings also record common-stock reserve changes, Nasdaq Listing Rule 5635(c)(4) award mechanics and officer/director indemnification terms within the company’s public-company governance framework.
Power Integrations (POWI) has a Form 144 notice reporting a proposed sale of 2,036 common shares with an aggregate market value of $93,758.80. The sale is listed as approximately 08/12/2025 on NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing shows 56,095,582 shares outstanding for the issuer, and states there were no securities sold by the seller in the past three months.
The filing details how the shares were acquired: restricted stock grants (194, 213, 665 shares on 11/01/2024, 02/01/2025, 04/01/2025 respectively), performance shares (574 on 12/31/2024), and purchases under the employee stock purchase plan (183 on 01/31/2025 and 207 on 07/31/2025, paid in cash). The filer affirms they have no undisclosed material adverse information about the issuer.
Power Integrations (POWI) – Form 4 insider filing
President & CEO Jennifer A. Lloyd reported two acquisitions of common stock on 08/01/2025:
- 52,487 shares acquired (Transaction Code A) at an indicated price of $0.00, lifting direct ownership to 52,487 shares.
- 20,995 additional shares acquired the same day at $0.00, increasing her direct holdings to 73,482 shares.
No dispositions, derivative transactions, or 10b5-1 plan indications were included. The filing, signed 08/05/2025, reflects only Ms. Lloyd as the reporting person.